ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney"

  • 2017 American Transplant Congress

    Financial Burden and Time to Returning to Work Among Living Kidney Donors.

    D. Larson, D. Berglund, D. Vock, A. Roman, J. Wiseman, H. Ibrahim, A. Matas.

    U of MN, Mpls

    Surveying our living kidney donor (LKD) population we learned (and reported) that: a) more than a quarter of our LKDs experienced substantial financial burden due…
  • 2017 American Transplant Congress

    Novel Therapies for Diabetic Kidney Disease.

    M. Nguyen, K. Kodama, M. Sarwal.

    University of California, San Francisco, San Francisco, CA

    Introduction: The development and progression of diabetic kidney disease (DKD) is thought to involve a combination of hemodynamic, metabolic, ischemic, and inflammatory factors; however, the…
  • 2017 American Transplant Congress

    The Adoption of Generic Immunosuppressant Medications Among Kidney and Liver Transplant Recipients Using the Colorado All Payer Claims Database.

    Q. Liu,1 A. Smith,1 J. Park,2 M. Oguntimein,3 S. Dutcher,3 G. Bello,1 M. Helmuth,1 M. Turenne,1 R. Balkrishnan,4 M. Fava,1 P. Sharma,2 C. Beil,1 A. Leichtman,1 J. Zee.1

    1Arbor Research Collaborative for Health, Ann Arbor, MI; 2U of Michigan, Ann Arbor, MI; 3Food and Drug Administration, Silver Spring, MD; 4U of Virginia, Charlottesville, VA

    Background: Substitution of generic for brand-name immunosuppressants has increased in solid organ transplantation following the expiration of brand patents. Our aim was to describe the…
  • 2017 American Transplant Congress

    Deciphering the Mechanism of Remote Ischemic Preconditioning and Its Potential Benefits in Ischemia/Reperfusion Injury by Metabolomics.

    S. Cho, S.-I. Min, S.-Y. Kim, M.-J. Cho, W. Cho, S. Ahn, S.-K. Min, J. Ha.

    Surgery, Seoul National University Hospital, Seoul, Korea

    IntroductionRemote ischemic preconditioning (RIPC) is a strategy inducing resistance against ischemia and reperfusion(IR) injury. But the mechanism and the time window of protection representing RIPC…
  • 2017 American Transplant Congress

    Prescription Opioid Use Before and After Kidney Transplant: Implications for Post-Transplant Outcomes.

    K. Lentine,1 N. Lam,2 D. Segev,3 D. Axelrod,4 Z. Zhang,1 H. Xiao,1 G. Hess,5 B. Kasiske,6 R. Gadi,1 R. Devraj,7 D. Brennan,8 H. Randall,1 M. Schnitzler.1,6

    1St. Louis Univ, St. Louis, MO; 2Univ Alberta, Edmonton, AB, Canada; 3Johns Hopkins, Baltimore, MD; 4East Carolina Univ, Greenville, NC; 5Symphony Health, Philadelphia, PA; 6Scientific Registry of Transplant Recipients, Minneapolis, MN; 7Southern Illinois Univ, Edwardsville, IL; 8Washington Univ, St. Louis, MO

    We previously identified associations of opioid use before kidney transplant (KTx) with post-KTx complications.To confirm and extend these findings, we examined a novel database wherein…
  • 2017 American Transplant Congress

    Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.

    T. Schachtner,1,2 P. Reinke.1,2

    1Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; 2Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany

    The rising prevalence of end-stage renal disease and chronic organ shortage calls more people upon to consider living kidney donation. The benefits for recipients and…
  • 2017 American Transplant Congress

    Twelve Hour Ex Vivo Normothermic Perfusion for the Assessment of High-Risk Discarded Deceased Donor Kidneys.

    I. Palma, I. Palma, Y. Smolin, S. Kabagambe, A. Perry, J. Sageshima, R. Perez.

    Department of Surgery, UC Davis Medical Center, Sacramento, CA

    Ex-Vivo Normothermic Perfusion (EVNP) has been shown to be useful to assess viability of high-risk deceased donor kidneys, with high renal blood flow and immediate…
  • 2017 American Transplant Congress

    Immunosuppressant Costs for Medicare Part D and Kidney Transplant Recipients Since the Introduction of Generic Formulations in an Incident Kidney Transplant Population.

    M. Helmuth,1 M. Turenne,1 J. Park,2 Q. Liu,1 M. Oguntimein,3 S. Dutcher,3 R. Balkrishnan,4 J. Zee,1 A. Smith,1 A. Leichtman.1

    1Arbor Research Collaborative for Health, Ann Arbor, MI; 2U of Michigan, Ann Arbor, MI; 3Food and Drug Administration, Silver Spring, MD; 4U of Virginia, Charlottesville, VA

    Background: Substitution of generics (GEN) for brand name (BN) immunosuppressants (IS) has increased in kidney transplant recipients (KTR) since the introduction of GEN mycophenolate mofetil…
  • 2017 American Transplant Congress

    The Associations Between Immunosuppression Use, Loss of Medicare and Kidney Allograft Outcomes.

    A. Hart,1,2 S. Gustafson,2 A. Wey,2 N. Hadley,2 A. Israni.2

    1Hennepin County Medical Center, Minneapolis; 2Scientific Registry of Transplant Recipients, Minneapolis

    Medicare coverage for kidney transplant recipients aged <65 years in the US ends 3 years posttransplant, but a significant proportion of recipients remain on Medicare…
  • 2016 American Transplant Congress

    c-Kit+ Cells Are Kidney-Specific Progenitor/Stem Cells with Regenerative Potential.

    S. Abreu Gomes,1 G. Goss,2 B. Goldstein,2 B. Seidler,3 D. Saur,3 J. Hare,2 E. Bevilaqua Rangel.1

    1Albert Einstein Hospital, Sao Paulo, SP, Brazil; 2University of Miami, Miami; 3Medizinische Klinik, Technische Universität München, Munich, Germany.

    Introduction: Identification of progenitor/stem cell populations in mammalian tissues is important for therapeutic applications and for understanding biological processes. We recently reported that c-Kit+ cells…
  • « Previous Page
  • 1
  • …
  • 83
  • 84
  • 85
  • 86
  • 87
  • …
  • 101
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences